Prions and manganese: A maddening beast
1Department of Biology and Biochemistry, University of Bath, Bath, UKBA2 7AY. bssdrb@bath.ac.uk
Abstract:
The prion protein is well known because of its association with prion diseases. These diseases, which include variant CJD, are unusual because they are neurodegenerative diseases that can be transferred between individuals experimentally. The prion protein is also widely known as a copper binding protein. The binding of copper to the prion protein is possibly necessary for its normal cellular function. The prion protein has also been suggested to bind other metals, and among these, manganese. Despite over ten years of research on manganese and prion disease, this interaction has often been dismissed or at best seen as a poor cousin to the involvement of copper. However, recent data has shown that manganese could stabilise prions in the environment and that chelation therapy specifically aimed at manganese can extend the life of animals with prion disease. This article reviews the evidence for a link between prions and manganese.
Insights
Manganese may play a crucial role in prion diseases, potentially stabilizing prions and offering therapeutic targets. Chelation therapy targeting manganese shows promise in extending lifespan in affected animals.
Area of Science:
- Neurodegenerative diseases
- Prion biology
- Metal-protein interactions
Background:
- Prion diseases, such as variant Creutzfeldt-Jakob disease (vCJD), are transmissible neurodegenerative disorders.
- The prion protein (PrP) is known for its association with these diseases and its role as a copper-binding protein.
- The interaction of PrP with other metals, particularly manganese (Mn), has been historically underestimated compared to copper.
Purpose of the Study:
- To review the existing evidence linking manganese to prion diseases.
- To highlight the emerging role of manganese in prion stabilization and disease progression.
- To explore the therapeutic potential of targeting manganese in prion disease treatment.
Main Methods:
- Literature review of studies investigating the PrP-manganese interaction.
- Analysis of data on manganese's effect on prion stability in the environment.
- Examination of results from chelation therapy trials targeting manganese in animal models.
Main Results:
- Recent findings suggest manganese can stabilize prions, potentially contributing to their environmental persistence.
- Chelation therapy specifically targeting manganese has demonstrated an ability to extend survival times in animal models of prion disease.
- The historical underestimation of the manganese-prion link is being challenged by new data.
Conclusions:
- Manganese represents a significant, yet underappreciated, factor in prion disease pathogenesis.
- Targeting manganese through chelation therapy offers a promising new avenue for treating prion diseases.
- Further research into the PrP-manganese interaction is warranted to fully understand its implications for disease and therapy.
Related Concept Videos
Microbes and Other Elemental Cycles
The Periodic Table and Organismal Elements
Periodic Table Provides Information...
The Periodic Table and Organismal Elements
Minerals
Acid Mine Drainage
Microbial Nutrition


